Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma

Background. LUZP2 is a protein limitedly expressed in the brain and spinal cord, while there are few studies on it in brain tumors. Low-grade glioma (LGG) is one of the most common brain tumors. However, the biological behavior of LGG is not very clear at present. This study was aimed at exploring t...

Full description

Bibliographic Details
Main Authors:	Yong Li, Gang Deng, Yangzhi Qi, Huikai Zhang, Hongxiang Jiang, Rongxin Geng, Zhang Ye, Baohui Liu, Qianxue Chen
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2020/9716720

Similar Items

Circulating Tumor Cells for Glioma
by: Huikai Zhang, et al.
Published: (2021-03-01)

Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
by: Yang Xu, et al.
Published: (2021-10-01)

Molecular Cloning of Luzp Gene and the Establishment of Luzp Knockout Mouse Model
by: Maud Wan-Ying Lee, et al.
Published: (2001)

Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
by: Yangzhi Qi, et al.
Published: (2020-11-01)

Downregulation of Death-associated Protein Kinase 3 and Caspase-3 Correlate to the Progression and Poor Prognosis of Gliomas
by: Ye Song, et al.
Published: (2016-01-01)

Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis
by: Yang Xu, et al.
Published: (2019-03-01)

Identifying circulating glioma cells and their clusters as diagnostic markers by a novel detection platform
by: Yangzhi Qi, et al.
Published: (2021-02-01)

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas
by: Kun Fan, et al.
Published: (2017-08-01)

Temporal Expression and Functional Implicaiton of LUZP in Brain
by: Mei-Hsin Cheng, et al.
Published: (2004)

Downregulation of Brain Enriched Type 2 MAGEs Is Associated With Immune Infiltration and Poor Prognosis in Glioma
by: Mohit Arora, et al.
Published: (2020-12-01)

AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway
by: Lun Gao, et al.
Published: (2020-07-01)

RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling pathway
by: Yang Xu, et al.
Published: (2020-08-01)

A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma
by: Wentao Liu, et al.
Published: (2021-02-01)

Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas.
by: Wei Du, et al.
Published: (2015-01-01)

Luzp is a novel modulator crucial for brain and cardiovascular development
by: Chia-Yi, Hsu, et al.
Published: (2008)

Expression LUZP in Murine Hippocampus After Adrenalectomy and Under Stress
by: Jing-Jing Chiu, et al.
Published: (2002)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
by: Li Gang, et al.
Published: (2013-01-01)

An Externally Validated Dynamic Nomogram for Predicting Unfavorable Prognosis in Patients With Aneurysmal Subarachnoid Hemorrhage
by: Ping Hu, et al.
Published: (2021-08-01)

Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.
by: Olga Martinho, et al.
Published: (2012-01-01)

Overexpression of FRAT1 Is Associated with Malignant Phenotype and Poor Prognosis in Human Gliomas
by: Geng Guo, et al.
Published: (2015-01-01)

PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas
by: Hao Zhang, et al.
Published: (2021-02-01)

High expression of cluster of differentiation 276 indicates poor prognosis in glioma
by: Linchen Li, et al.
Published: (2021-07-01)

Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis
by: Cheng Zhang, et al.
Published: (2018-12-01)

Increased Expression of microRNA-17 Predicts Poor Prognosis in Human Glioma
by: Shengkui Lu, et al.
Published: (2012-01-01)

Downregulation of ALDOB is associated with poor prognosis of patients with gastric cancer
by: He J, et al.
Published: (2016-10-01)

Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis.
by: Lili Liu, et al.
Published: (2012-01-01)

Stress Response of Adult Luzp-Knouck-out/lacZ Knock-in Heterozygous Mice
by: Ying-Chih Wang, et al.
Published: (2009)

LUZP1 Controls Cell Division, Migration and Invasion Through Regulation of the Actin Cytoskeleton
by: Laura Bozal-Basterra, et al.
Published: (2021-04-01)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
by: Jialin Wang, et al.
Published: (2021-02-01)

High LAMC1 expression in glioma is associated with poor prognosis
by: Liu J, et al.
Published: (2019-05-01)

High PYGL Expression Predicts Poor Prognosis in Human Gliomas
by: Chang-yi Zhao, et al.
Published: (2021-06-01)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
by: Basel Abu-Jamous, et al.
Published: (2017-06-01)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
by: Jiajie Lu, et al.
Published: (2021-06-01)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
by: Zhendong Liu, et al.
Published: (2021-08-01)

Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence
by: Wei Zhou, et al.
Published: (2019-10-01)

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
by: Jingshu Wang, et al.
Published: (2017-10-01)

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
by: Zhendong Liu, et al.
Published: (2021-05-01)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
by: Hongbo Zhang, et al.
Published: (2020-12-01)

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
by: Jin-Zhang Sun, et al.
Published: (2021-01-01)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
by: Yujia Xiong, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_kbb17b8uj5bo645h48j1hufkk1